InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
3 hedge funds and large institutions have $5K invested in InspireMD, Inc. Series B Warrants in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
400% more capital invested
Capital invested by funds: $1K → $5K (+$4K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$472 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$128 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$472 | +59,692 | +13% |
|
2
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| – | +$128 | +16,223 | New |
|
NSPRZ Hedge Fund Activity: Q1 2020 in Review
3 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q1 2020, worth a combined $5K — up 400% from $1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NSPRZ positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $472.
- 3 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q1 2020, up from 2 in Q4 2019.
- Funds reported $5K of InspireMD, Inc. Series B Warrants stock for Q1 2020, up 400% quarter-over-quarter.
- 1 fund opened new InspireMD, Inc. Series B Warrants positions in Q1 2020 and 0 closed out, a net change of +1 holder.
- The largest InspireMD, Inc. Series B Warrants buyer in Q1 2020 was Susquehanna International Group, an estimated $472 added.
Based on aggregated 13F filings for Q1 2020.